The Global Shrimp Disease Diagnostics Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. The market is primarily driven by increasing occurrence of viral infections in shrimp farming. However, high cost of investment associated with the commercialization novel shrimp diseases diagnostics through pioneering technologies might obstruct the market growth.
The shrimp disease diagnostics market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA and Emerging Countries such as China, Thailand and India. Due to the high viral-borne endemic shrimp diseases, countries such as China, Thailand, and India are estimated to be the fastest-growing regional markets for shrimp disease diagnostics, and are poised to offer significant opportunities.
With a large number of ongoing research initiatives pertaining to shrimp disease, the demand for shrimp disease diagnostics is estimated to grow significantly over the forecast period. Moreover, mergers & acquisitions and research-based collaboration agreements by key manufacturers in the shrimp disease diagnostics market are also among factors estimated to fuel the growth of the market.
Get More Information about : http://www.marketgrowthanalysis.com/reports/sample/197
The global shrimp disease diagnostics market is primarily segmented based on different product type, reagents kits and regions.
On the basis of product type:
* WSSV (White Spot Syndrome Virus)
* TSV (Taura Syndrome Virus)
* IHHNV (Infectious Hypodermal and Hematopoietic Virus)
* YHV/GAV (Yellow Head/Gill Associated Virus)
* HPV (Hepatopancreatic Parvovirus)
On the basis of reagents kits:
* Assay Based Kits
* Rapid Testing Kits
On the basis of End User:
*Education and Research Institutes
Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa
The shrimp disease diagnostics market report tracks some of the key companies operating in the global shrimp disease diagnostics market, which include FUJIKURA KASEI CO., LTD., Thermo Fisher Scientific, GeneReach Biotechnology Corp., HiMedia Laboratories, GeneReach Biotechnology Corp., Speedy Assay Sdn Bhd, Lab – Ind Resource Sdn Bhd, REAGEN LLC, Aura Biotechnologies, and SURE Marketing Company, Inc., among others.
Request for Table of Contents: http://www.marketgrowthanalysis.com/reports/toc/197